SphK1 inhibitors (SphynKx Therapeutics)

N/A

Report date: 2025/03/20 10:11:58
NME

Base Information

Drug NameSphK1 inhibitors (SphynKx Therapeutics)
Drug Alias Namesphingosine kinase-1 inhibitors (SphynKx Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase 1 inhibitors
TargetsSphingosine kinase 1
Therapy Area/IndicationsNerve DegenerationFibrosisAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSphynKx Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesSphynKx Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNerve DegenerationFibrosisAutoimmune Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A